In the current study, expression of TPX2 and TTK was associated with oncogenic state in colon adenocarcinoma (COAD), while employing gene set enrichment analysis we constructed the gene-drug network for potential therapeutic targeting of TPX2/TTK networks and their potential implementation in CRC targeted therapy. The gene discussed is TPX2; the disease is colorectal carcinoma.